Microsoft word - cv_vivek gurdutt.docx
Board Certified in Otolaryngology-Head and Neck Surgery
Fellow of the American College of Surgeons CLINICAL INTERESTS
General Otolaryngology, Sialoendoscopy/Salivary Diseases, Head and Neck Tumors, Sinus Disease EDUCATION
Bryan Hemming Endowed Fellowship in Head and Neck Cancer
University of California, San Francisco
San Francisco, CA
Otolaryngology/Head and Neck Surgery
Rush University Medical Center
Rush University Medical Center
Indiana University School of Medicine
Michigan State University
East Lansing, Michigan
Bachelor of Science with High Honor
Gurudutt VV, Genden EM. Scalp Reconstruction. Reconstruction of the Head and Neck.
Chapter 7. Ed. Genden EM. Thieme Medical Publishers, New York, 2012
Tong C, Lau K, Rivera M, Cannan D, Aguirre-Ghiso J, Sidora A, Gupta V, Forsythe K, Do E,
Misiukiewicz K, Gurudutt V, Teng M, Packer S, Genden E, Kao J. Prognostic Significance of
p16 in Locoregionally Advanced Head and Neck Cancer Treated with Concurrent 5-Fluorouracil,
Hydroxyurea, Cetuximab and IMRT. Oncology Reports. 2012.
Vila PM, Park CW, Pierce MC, Goldstein GH, Levy L, Gurudutt VV, Polydorides AD,
Godbold JH, Teng MS, Genden EM, Miles BA, Anandasabapathy S, Gillenwater AM, Richards-
Kortum R, Sikora AG. Discrimination of Benign and Neoplastic Mucsoa with a High-Resolution
Microendoscope (HRME) in Head and Neck Cancer. Annals of Surgical Oncology.
Del Signore A, Gurudutt VV. Sialoendoscopy in the Management of Salivary Diseases. Recent
Advances in Head and Neck Surgery. Chapter 12. Eds. Lalwani A, Pfister M. Jaypee Bros. In
Kleinberger A, Osborn IP, Gurudutt VV. Airway Emergencies and the Difficult Airway. Anesthesiology and Otolaryngology. Chapter 8. Eds. Govindaraj S, Levine A. In editing. Gurudutt VV, Genden EM. Cutaneous Squamous Cell Carcinoma of the Head and Neck. Journal of Skin Cancer.
2011:502723. Feb 21 2011, epub. Kao J, Genden EM, Chen CT, Rivera M, Tong CC, Misikiewicz K, Gupta V, Gurudutt V, Teng M, Packer SH. Phase I Trial of Concurrent Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer. Cancer
. Jan 18 2011, epub. Kao J, Genden EM, Gupta V, Policarpio E, Burri R, Rivera M, Gurudutt V, Som P, Teng M, Packer SH. Phase II Trial of Concurrent 5-Fluorouracil, Hydroxyurea, Cetuximab and Hyperfractionated Intensity Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer. Cancer.
2011, 117 (2): 318-26. Levy L, Smith C, Gurudutt V, Teng M, Rivera M, Anadasabapathy S, Genden E, Gillenwater A, Richards-Kortum R, Sikora A. Ex vivo high resolution imaging with a miniatrurized microendoscope to discriminate between benign and malignant mucosa in the upper aerodigestive tract. Laryngoscope
. 2010;120 Suppl (4): S162. Ng SA, Solano IC, Gurudutt VV, Som PM. A Rare Case of Reidel’s Thyroiditis with Associated Vocal Cord Paralysis: CT and MR Imaging Features. American Journal of Neuroradiology. May 5 2011, epub. Fitzhugh VA, Maniar KP, Gurudutt VV, Rivera M, Chen H, Wu M. Fine-Needle Aspiration Biopsy of Granular Cell Tumor of the Tumor of the Tongue: A Technique for the Aspiration of Oral Lesions. Diagnostic Cytopathology. Jun 12, 2009. Gurudutt VV, Wang SJ, Eisele DW. Management of Cervical Lymph Node Metastases. Practical Head and Neck Oncology. Chapter 19. Ed. Petruzelli. Plural Publishing, 2009. Gurudutt, VV. The Planning of a Mission. Indianapolis Medical Society Bulletin.
May, 1999; 88(9): 25, 27. Dickson TJ, Gurudutt V, Nguyen AQ, Kumfer K, Maxted W, Brown J, Mohamed Y, Sharp T, Aufiero TX, Fineberg N, March KL. Establishment of a Clinically Correlated Human Pericardial Fluid Bank: Evaluation of Intrapericardial Diagnostic Potential. Clinical Cardiology.
Jan, 1999; 22 (Suppl. I): I40-2. Franchetti P, Cappellacci L, Sheikha GA, Jayaram HN, Gurudutt VV, Sint T, Schneider BP, Jones WD, Goldstein BM, Perra G, De Montis A, Loi AG, La Colla P, Grifantini M. Synthesis, Structure, and Antiproliferative Activity of Selenophenfurin, an Inosine 5’-Monophosphate Dehydrogenase Inhibitor Analogue of Selenazofurin. Journal of Medicinal Chemistry.
May 23, 1997; 40 (11): 1731-7.
BREOX FMT 30 INTRODUCTION BREOX FMT 30 is a cost-effective performance anti-foam with the significant added benefits, over more traditional antifoams, of improved processing and yields in microbiological fermentation applications. It is also suitable for use in aqueous systems requiring an anti-foam which will operate specifically at temperatures around 30°C, for example warm wate
Asthma Attack We have formed our policy and procedures for Asthma through the Warrington Schools Policy, St Joseph’s Catholic Primary school have adopted this policy and we feel it would benefit both the children and our staff to adopt this policy for our own club for familiarity for al involved. Asthma maybe manifested through the fol owing symptoms: • Coughing • Tight Chest • Wheez